Last reviewed · How we verify
NCT05872061: SenegalMPS
Senegal Market Study for Food-to-Food Fortified (F2F) Instant Porridge Flours
trial testing Acceptability of food-to-food fortified (FtFF) instant porridge flours in Iron-deficiency in 1,800 participants. Completed in 30 April 2022.
30 April 2022
Quick facts
| Lead sponsor | Purdue University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,800 |
| Start date | 27 January 2022 |
| Primary completion | 30 April 2022 |
| Estimated completion | 30 April 2022 |
| Sites | 1 location across Senegal |
Drugs / interventions tested
- Acceptability of food-to-food fortified (FtFF) instant porridge flours
Conditions studied
- Iron-deficiency — all drugs for Iron-deficiency →
- Vitamin A Deficiency — all drugs for Vitamin A Deficiency →
Sponsor
Purdue University
Who can join
18 and older, any sex, with Iron-deficiency or Vitamin A Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall hypotheses is that a product designed with optimized nutritional characteristics, based on consumer preferences and leveraging local nutrient dense ingredients, can successfully deliver nutrition through sustainable market-driven approaches. The objectives of this study were 1) to assess the nutritional adequacy of urban Senegalese households with children and 2) to determine the market potential of a locally sourced and manufactured, blended fortified, cereal-based product for the improvement of micronutrient deficiencies among children aged 24-60 months. This study simulates a market study, the investigators will conduct a product launch, determine market potential based on sales, evaluate marketing strategy to increase market share, and model the nutritional contribution of FtFF/traditionally fortified product for iron, zinc, and vitamin A. The investigators expect to provide a thorough evaluation of a business-driven strategy (for profit, social enterprise) as a sustainable tool to decrease micronutrient deficiencies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05872061
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Iron-deficiency
Currently open trials in the same condition.
- NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
- NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
- NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
- NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
Other Purdue University trials
Trials by the same sponsor.
- NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
- NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
- NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
- NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
- NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05872061 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Purdue University
- Last refreshed: 1 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05872061.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing